1. Alexion says “no” to investor proactive sale demand — FDA approves first copycats of Novartis MS drug Gilenya — $178M stockpile of Merck ebola vaccine authorized — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Gilead Sciences

Anonymous board for Gilead Sciences


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    5
    Views:
    603
  2. anonymous
    Replies:
    10
    Views:
    3,716
  3. anonymous
    Replies:
    35
    Views:
    4,935
  4. anonymous
    Replies:
    6
    Views:
    960
  5. anonymous
    Replies:
    3
    Views:
    639
  6. anonymous
    Replies:
    65
    Views:
    11,002
  7. anonymous
    Replies:
    6
    Views:
    1,490
  8. anonymous
    Replies:
    2
    Views:
    827
  9. anonymous
    Replies:
    1
    Views:
    769
  10. anonymous
    Replies:
    5
    Views:
    1,219
  11. anonymous
    Replies:
    14
    Views:
    6,309
  12. anonymous
    Replies:
    11
    Views:
    1,768
  13. anonymous
    Replies:
    107
    Views:
    21,045
  14. anonymous
    Replies:
    16
    Views:
    1,882
  15. anonymous
    Replies:
    2
    Views:
    1,637
  16. anonymous
    Replies:
    1
    Views:
    1,011
  17. anonymous
    Replies:
    3
    Views:
    1,170
  18. anonymous
    Replies:
    16
    Views:
    5,125
  19. anonymous
    Replies:
    3
    Views:
    1,516
  20. Delia Ramirez
    Replies:
    1
    Views:
    733

Thread Display Options

Loading...